Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis
Top Cited Papers
- 1 November 2003
- journal article
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 11 (11) , 821-830
- https://doi.org/10.1016/s1063-4584(03)00163-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Vascular mechanisms in osteoarthritisBest Practice & Research Clinical Rheumatology, 2001
- Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitorsOsteoarthritis and Cartilage, 2001
- Animal Models of Arthritis: Relevance to Human DiseaseToxicologic Pathology, 1999
- Mono‐iodoacetate‐induced experimental osteoarthritis. A dose‐response study of loss of mobility, morphology, and biochemistryArthritis & Rheumatism, 1997
- Weight bearing as an objective measure of arthritic pain in the ratJournal of Pharmacological and Toxicological Methods, 1994
- Histomorphological Studies on the Effect of Recombinant Human Superoxide Dismutase in Biochemically Induced OsteoarthritisPharmacology, 1993
- Naproxen A Reappraisal of its Pharmacology, and Therapeutic Use in Rheumatic Diseases and Pain StatesDrugs, 1990
- Triamcinolone hexacetonide protects against fibrillation and osteophyte formation following chemically induced articular cartilage damageArthritis & Rheumatism, 1985
- Immobilization ameliorates chemically‐induced articular cartilage damageArthritis & Rheumatism, 1984
- A Multiple Comparison Procedure for Comparing Several Treatments with a ControlJournal of the American Statistical Association, 1955